Mitapivat versus Placebo for Pyruvate Kinase Deficiency. Reply
- PMID: 35767454
- DOI: 10.1056/NEJMc2206275
Mitapivat versus Placebo for Pyruvate Kinase Deficiency. Reply
Comment on
-
Mitapivat versus Placebo for Pyruvate Kinase Deficiency.N Engl J Med. 2022 Jun 30;386(26):2538-2539. doi: 10.1056/NEJMc2206275. N Engl J Med. 2022. PMID: 35767453 No abstract available.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources